| |
| |
|
| Insider
Information: |
Giraudo Bryan |
| Relationship: |
COO/CFO |
| City: |
Newark |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
102,737 |
|
|
Indirect Shares
|
388,010 |
|
|
| Direct
Value |
$313,448 |
|
|
|
Indirect Value
|
$455,047 |
|
|
| Total
Shares |
490,747 |
|
|
| Total
Value |
$768,495 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
3
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
5
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -24.7%
|
-102.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Protagonist Therapeutics, Inc |
PTGX |
Director |
2019-12-03 |
10,000 |
2019-12-03 |
8,000 |
Premium* |
|
|
Gossamer Bio Inc |
GOSS |
COO/CFO |
2024-03-27 |
92,737 |
2024-03-27 |
380,010 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GOSS |
Gossamer Bio Inc |
COO/CFO |
• – – |
2024-03-27 |
4 |
S |
$1.16 |
$7,431 |
D/D |
(6,430) |
92,737 |
0 |
% |
|
| GOSS |
Gossamer Bio Inc |
COO/CFO |
• – – |
2023-11-13 |
4 |
B |
$0.56 |
$112,880 |
I/I |
200,000 |
380,010 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
COO/CFO |
• – – |
2023-07-24 |
4 |
A |
$1.82 |
$98,316 |
I/I |
54,020 |
180,010 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
COO/CFO |
• – – |
2023-04-04 |
4 |
B |
$1.02 |
$56,095 |
I/I |
55,000 |
125,990 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
COO/CFO |
• – – |
2023-03-20 |
4 |
B |
$0.97 |
$48,435 |
I/I |
50,000 |
70,990 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
COO/CFO |
• – – |
2022-07-15 |
4 |
B |
$7.21 |
$99,995 |
I/I |
13,869 |
20,990 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
COO/CFO |
• – – |
2022-03-23 |
4 |
S |
$8.92 |
$95,587 |
D/D |
(10,722) |
99,167 |
0 |
% |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2021-03-23 |
4 |
S |
$9.48 |
$52,046 |
D/D |
(5,490) |
109,889 |
0 |
% |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2021-02-25 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
115,379 |
0 |
- |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2020-10-14 |
4 |
B |
$10.01 |
$30,036 |
I/I |
3,000 |
7,121 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2020-06-23 |
4 |
B |
$12.96 |
$25,922 |
I/I |
2,000 |
4,121 |
1.99 |
% |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2020-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
46,500 |
70,379 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • – |
2019-12-03 |
4 |
B |
$5.70 |
$45,620 |
I/I |
8,000 |
8,000 |
2.1 |
- |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2019-09-26 |
4 |
B |
$16.78 |
$18,810 |
I/I |
1,121 |
2,121 |
1.99 |
- |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2019-05-30 |
4 |
B |
$18.70 |
$18,700 |
I/I |
1,000 |
1,000 |
1.99 |
- |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2019-02-12 |
4 |
B |
$16.00 |
$96,000 |
D/D |
6,000 |
23,879 |
2.74 |
- |
|
| GOSS |
Gossamer Bio Inc |
Chief Financial Officer |
• – – |
2019-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
17,879 |
17,879 |
0 |
- |
|
| PTGX |
Protagonist Therapeutics,... |
Director |
– • – |
2017-05-16 |
4 |
B |
$6.46 |
$64,566 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
